ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB9 | ATP-binding cassette, sub-family B (MDR/TAP), member 9 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ACER1 | Alkaline ceramidase 1 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ADCY7 | Adenylate cyclase 7 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALG3 | ALG3, alpha-1,3- mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG8 | ALG8, alpha-1,3-glucosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ANO10 | Anoctamin 10 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ANO2 | Anoctamin 2, calcium activated chloride channel | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO8 | Anoctamin 8 | Predicted membrane proteins
| | | | | Expressed in all |
ATP11B | ATPase, class VI, type 11B | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP7A | ATPase, Cu++ transporting, alpha polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ATP7B | ATPase, Cu++ transporting, beta polypeptide | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CLN3 | Ceroid-lipofuscinosis, neuronal 3 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CLN8 | Ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
COQ2 | Coenzyme Q2 4-hydroxybenzoate polyprenyltransferase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
COX10 | Cytochrome c oxidase assembly homolog 10 (yeast) | Disease related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
COX15 | Cytochrome c oxidase assembly homolog 15 (yeast) | Disease related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
DGAT1 | Diacylglycerol O-acyltransferase 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
EDNRB | Endothelin receptor type B | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
FZD1 | Frizzled class receptor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
G6PC | Glucose-6-phosphatase, catalytic subunit | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
G6PC2 | Glucose-6-phosphatase, catalytic, 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
GPAA1 | Glycosylphosphatidylinositol anchor attachment 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
GPR108 | G protein-coupled receptor 108 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
GPR37L1 | G protein-coupled receptor 37 like 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
GPR64 | G protein-coupled receptor 64 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPR89A | G protein-coupled receptor 89A | Predicted membrane proteins
| | | | | Expressed in all |
GPRC5C | G protein-coupled receptor, class C, group 5, member C | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
HHAT | Hedgehog acyltransferase | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ITPR3 | Inositol 1,4,5-trisphosphate receptor, type 3 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
KCNT1 | Potassium channel, subfamily T, member 1 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
LMF1 | Lipase maturation factor 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
MBOAT4 | Membrane bound O-acyltransferase domain containing 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
MBOAT7 | Membrane bound O-acyltransferase domain containing 7 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MFSD10 | Major facilitator superfamily domain containing 10 | Predicted membrane proteins
| | | | | Expressed in all |
MFSD7 | Major facilitator superfamily domain containing 7 | Predicted membrane proteins
| | | | | Mixed |
MYADM | Myeloid-associated differentiation marker | Predicted membrane proteins Transporters
| | | | | Expressed in all |
MYADML2 | Myeloid-associated differentiation marker-like 2 | Predicted membrane proteins
| | | | | Tissue enriched |
NIPA2 | Non imprinted in Prader-Willi/Angelman syndrome 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
NIPAL4 | NIPA-like domain containing 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |